Douglas Krakower

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications
    Douglas Krakower
    Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Curr HIV/AIDS Rep 8:241-8. 2011
  2. ncbi What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review
    Douglas Krakower
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Ann Intern Med 157:490-7. 2012
  3. ncbi Engaging healthcare providers to implement HIV pre-exposure prophylaxis
    Douglas Krakower
    Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Curr Opin HIV AIDS 7:593-9. 2012
  4. ncbi Antiretroviral medication and HIV prevention: new steps forward and new questions
    Kenneth H Mayer
    Fenway Health and Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Ann Intern Med 156:312-4. 2012
  5. ncbi The Promise of Antiretrovirals for HIV Prevention
    Charlene Flash
    Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Suite GB, Boston, MA, USA
    Curr Infect Dis Rep 14:185-93. 2012

Collaborators

Detail Information

Publications5

  1. ncbi Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications
    Douglas Krakower
    Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Curr HIV/AIDS Rep 8:241-8. 2011
    ..If future studies confirm the safety and efficacy of tenofovir gel and oral PrEP, successful implementation of these strategies could significantly impact the HIV epidemic...
  2. ncbi What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review
    Douglas Krakower
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Ann Intern Med 157:490-7. 2012
    ..Issues related to cost and insurance coverage are also discussed. Recent data suggest that PrEP, combined with other prevention strategies, holds promise in helping to curtail the HIV epidemic...
  3. ncbi Engaging healthcare providers to implement HIV pre-exposure prophylaxis
    Douglas Krakower
    Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Curr Opin HIV AIDS 7:593-9. 2012
    ..Therefore it is critical to understand provider knowledge, practices, and attitudes towards PrEP prescribing, and to develop strategies for engaging and training providers to provide PrEP...
  4. ncbi Antiretroviral medication and HIV prevention: new steps forward and new questions
    Kenneth H Mayer
    Fenway Health and Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Ann Intern Med 156:312-4. 2012
    ..However, a substantial gap exists between current expenditures and unmet needs, which suggests that mobilization of political will is needed for this combination approach to be successful...
  5. ncbi The Promise of Antiretrovirals for HIV Prevention
    Charlene Flash
    Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Suite GB, Boston, MA, USA
    Curr Infect Dis Rep 14:185-93. 2012
    ..Ongoing research will help characterize the role for oral and topical formulations and help quantify potential benefits in sub-populations at risk for HIV acquisition...